Harvard Bioscience (HBIO) announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. DeNelsky will also serve on the Board’s Nominating and Governance Committee.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HBIO:
- Harvard Bioscience Offers CFO $100K Retention Bonus
- Harvard Bioscience at Risk of Nasdaq Delisting: Implications for Investors and Business Stability
- Harvard Bioscience Reports Q2 2025 Financial Results
- Harvard Bioscience Surpasses Revenue Guidance Amid Challenges
- Harvard Bioscience Amends Credit Agreement with Lenders